Patients who repeatedly experience pulmonary embolism may wish to try certain medicines to prevent the formation of new blood clots and arrest size increase in existing clots.
Anticoagulants are commonly prescribed following pulmonary embolism or preceding a likely episode. Anticoagulants are typically taken for three months after an episode in an effort to reduce the recurrence of another blood clot; however, if the risk of recurrence remains high, they may be prescribed indefinitely.
Depending on a patient’s medical history and the severity, a wide variety of anticoagulants are prescribed. Hospitalization following a clot typically involves anticoagulants being administered through an IV drip or as a shot. Patients taking anticoagulants in the long-term often do so with pill medications.
The most common kinds of anticoagulants are Apixaban, Dabigatran, Edoxaban, Heparin, Rivaroxaban, and Warfarin.
Thrombolytic drugs, a more uncommon form of pulmonary embolism treatment, work to dissolve a blood clot directly. However, since they greatly increase the chance of serious bleeding and other complications, they are normally reserved for particularly life-threatening circumstances.
Featured Image: twitter